Trading Ichimoku

Arena Pharmaceuticals has started to break out of its resistance and is now heading higher. One of the early catalyst was ARNA signing up with a marketing or sales partner. And the second catalyst is FDA assessment of Vivus drug potential ( Note : Vivus is ARNA competitor). The key thing to note here is [...]

Background. A member in the forum ask about CHBT. Personally, I am not into FA and do not know how to dissect the earnings reports. From what I can gather, CHBT suffer a drop in share price based on 2 possible reasons: 1. share dilution as they raise more cash (but did not highlight how [...]

Immunomedics (IMMU) has just breakout of the kumo resistance. Next resistance is around $4.30. Volume is already higher than average within the first hour.